AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Development of a FibroScan Liver Examination Using a Single Probe

RecruitingNAAges 18 Years - anyAllEchosens
💬

In plain words

What the trial is, and whether it could suit you

This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (M and XL).

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients (≥ 18 years of age). * Patient followed with a chronic liver disease. * Adult patient able to give his written consent. * For European sites: patient affiliated to the healthcare system. Exclusion Criteria: * Vulnerable patients. * Patients with ascites. * Patients with heart failure. * Patients with acute hepatitis. * Patients with biliary obstruction.
💊

What it tests

  • Research FibroScan
📍

Where

4 sites
CHRU de Besançon
Besançon, France
Hôpital St Eloi- CHU Montpellier
Montpellier, France
Hôpital Paris Saclay
Orsay, France
Prince of Wales Hospital the Chinese University of Hong Kong
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy